Primary study · included by 3 reviews

Does intra-articular injection of tenoxicam after arthrocentesis heal outcomes of temporomandibular joint osteoarthritis? A randomized clinical trial.

Bayramoglu 2023 · Bayramoglu Zeynep, Yavuz Günay Yapici, Keskinruzgar Aydın, et al. · BMC oral health · 2023

Included by

Advanced, pharmacological and complementary interventions for chronic or recurrent orofacial pain conditions: a systematic evidence map with selective meta-analyses.

Non-Cochrane · intervention · 2026 · cited as Bayramoglu 2023 · Reference list [135]

The review does not say which of its outcomes this study informs.

Efficacy and Safety of Intra-Articular Therapies for Temporomandibular Disorders: A Systematic Review and Meta-Analysis.

Non-Cochrane · intervention · 2026 · cited as Bayramoglu 2023 · Table 1; reference list

The review does not say which of its outcomes this study informs.

Effectiveness of arthrocentesis versus other therapeutic modalities in patients with temporomandibular disorders. Systematic review and meta-analysis.

Non-Cochrane · intervention · 2026 · cited as Bayramoglu 2023 · Table 1; Figures 4-8; reference 34

Outcome this study informs	Pooled effect	Evidence	Certainty
Pain intensity (VAS) Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents vs Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols	Meta-regression coefficient (beta) -1.609 [-5.033, 1.816]	NR	GRADE not reported
Maximum mouth opening (MMO) TMJ arthrocentesis, alone or with adjunctive intra-articular agents vs Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) · Follow-up from 1 month to 5 years across trials (mean 53 weeks)	SMD -0.67 [-1.14, -0.20]	14 studies · 549 participants	Low
Pain intensity (VAS) TMJ arthrocentesis, alone or with adjunctive intra-articular agents vs Other therapeutic modalities (conservative therapy, intra-articular injections, arthroscopy, alternative arthrocentesis protocols) · Follow-up from 1 month to 5 years across trials (mean 53 weeks)	MD -0.25 [-1.09, 0.59]	26 studies · 947 participants	Very low
Maximum mouth opening (MMO) Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents vs Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols	Meta-regression coefficient (beta) -0.067 [-0.156, 0.021]	NR	GRADE not reported
Pain intensity (VAS) Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents vs Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols	Meta-regression coefficient (beta) -0.028 [-0.125, 0.069]	NR	GRADE not reported
Maximum mouth opening (MMO) Temporomandibular joint arthrocentesis, alone or with adjunctive intra-articular agents vs Other treatments: conservative therapy (splints, physiotherapy, drugs), intra-articular injections, arthroscopy, or alternative arthrocentesis protocols	Meta-regression coefficient (beta) -0.681 [-3.831, 2.470]	NR	GRADE not reported

3 including reviews in total.